Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
Quel est le ratio P/E de Becton Dickinson and Co (BDX) ?
Le ratio P/E de Becton Dickinson and Co est de 26.2903
Qui est le CEO de Becton Dickinson and Co ?
Mr. Thomas Polen est le Chairman of the Board de Becton Dickinson and Co, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action BDX ?
Le prix actuel de BDX est de $155.9, il a augmenté de 0.37% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Becton Dickinson and Co ?
Becton Dickinson and Co appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Becton Dickinson and Co ?
La capitalisation boursière actuelle de Becton Dickinson and Co est de $44.3B
Est-ce que Becton Dickinson and Co est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 15 analystes ont établi des notations d'analystes pour Becton Dickinson and Co, y compris 4 achat fort, 4 achat, 10 maintien, 0 vente et 4 vente forte